Results
1 -
10 of
25
(Click
here to explore results)
Kinase Drug Discovery, Chapter 6 Non-Protein Kinases as Therapeutic Targets . Jeroen C. Verheijen, David J. Richard, Arie Zask
, 2012
, Pages 161-217
Accounts in Drug Discovery: Case Studies in Medicinal Chemistry, Chapter 14 Uncoupling Neuroprotection from Immunosuppression: the Discovery of ILS-920 . Edmund I. Graziani
, 2011
, Pages 316-331
Natural Product Chemistry for Drug Discovery, Chapter 11 A Snapshot of Natural Product-Derived Compounds in Late Stage Clinical Development at the End of 2008 . Mark S. Butler
, 2009
, Pages 321-354
Anti-aging Drugs: From Basic Research to Clinical Practice, CHAPTER 14 Extending Lifespan by Inhibiting the Mechanistic Target of Rapamycin (mTOR) . Dudley W. Lamming
, 2017
, Pages 352-375
Macrocycles in Drug Discovery, CHAPTER 1 Bioactive Macrocycles from Nature . David J. Newman, Gordon M. Cragg
, 2015
, Pages 1-36
Privileged Scaffolds in Medicinal Chemistry: Design, Synthesis, Evaluation, Chapter 13 Natural Product Scaffolds of Value in Medicinal Chemistry . David J. Newman, Gordon M. Cragg
, 2016
, Pages 348-378
Kinase Drug Discovery, Subject Index
, 2012
, Pages 303-318
Drug Discovery for Psychiatric Disorders, CHAPTER 15 Emerging Research towards the Understanding and Treatment of Autism . Paul Wang, Rebecca Hammond, Friso Postma, Aileen Healy
, 2012
, Pages 384-415
Ion Mobility-Mass Spectrometry: Fundamentals and Applications, CHAPTER 6 Field Asymmetric Ion Mobility Spectrometry (FAIMS) for Advanced Mass Spectrometry . M. Belford, S. Prasad, S. Peterman, E. Bonneil, J. Lanoix, C. Durette, P. Thibault, K. Motamedchaboki, R. Huguet, D. Lopez-Ferrer, R. D. Melani, K. Srzentić, L. Fornelli, N. L. Kelleher, R. W. Purves, K. Walker, Y. Zhu, G. de Albuquerque Cavalcanti, N. Wijeratne, C. Boeser
, 2022
, Pages 132-162
Designing Multi-Target Drugs, Chapter 11 Combination Agents Versus Multi-Targeted Agents – Pros and Cons . Jose G. Monzon, Janet Dancey
, 2012
, Pages 155-180